Wikipedia -WSS

Wikipedia

author：focus 2025-09-29 13:27:52 Page View：2958

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Everything to know for the next Powerball drawing as jackpot hits $1 billion
Next article： Cancer drug shortages should be causing more outrage

Wikipedia

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

Europe sees delivery challenges ahead on Alzheimer's therapies

VialsandpackagingforLeqembi,anewAlzheimer'smedicationapprovedintheU.S.,butnotyetinEurope.Illustratio

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

2:07E.JeanCarrollwalksoutofManhattanfederalcourt,May9,2023,inNewYork.JohnMinchillo/AP,FILETheJustice

Wikipedia

explore

Wikipedia

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed